Chargebee vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

Chargebee

LeaderSubscription Services

General

Chennai subscription billing platform at $202.6M 2024 revenue (+62.9% YoY); $255M total at $3.5B valuation with Gartner Magic Quadrant Leader (first-ever) and INAI AI payments acquisition competing with Zuora for subscription management.

AI VisibilityBeta
Overall Score
A90
Category Rank
#66 of 1167
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
85
Perplexity
86
Gemini
85

About

Chargebee is a Chennai, India-based subscription management and recurring billing platform — backed with $255 million in total funding at a $3.5 billion valuation — providing 18,000+ subscription businesses with comprehensive SaaS infrastructure for subscription billing, revenue recognition (ASC 606, IFRS 15), dunning and collections, and analytics. In 2024, Chargebee reported $202.6 million in revenue (62.9% year-over-year growth) and was named a Leader in the first-ever Gartner Magic Quadrant for Recurring Billing Applications — validating the subscription billing platform category's maturity. The platform supports complex pricing models from simple flat-rate subscriptions to sophisticated usage-based, metered, and hybrid billing structures. Chargebee has expanded through acquisitions: RevLock (revenue recognition automation), Brightback (churn prevention), INAI (AI-powered payments intelligence and analytics, acquired 2025), and Trainn (customer training). Founded in 2011 by Krish Subramanian, Rajaraman Santhanam, Saravanan KP, and Thiyagarajan Thiyagu.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

90
Overall Score
90
#66
Category Rank
#9
74
AI Consensus
60
stable
Trend
stable
85
ChatGPT
99
86
Perplexity
99
85
Gemini
83
83
Claude
96
94
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.